healthblogs.net Blogs

According to Chris Kenton of SmartMarketers.com’s Inspire Blog, “Surprisingly few companies… have protocols in place to manage social media disasters as they unfold — even those that have sophisticated crisis management protocols in place for non-social media issues.”

Many pharmaceutical companies…

In comments to the FDA, Johnson & Johnson (JNJ) stated “Flexibility in regulatory approach is crucial in the evolving digital world.” The comment was part of an 8-page document submitted to Docket No. FDA‐2009‐N‐0441 regarding Promotion of FDA‐Regulated Medical Products…

Novartis submitted 6 pages of comments to Docket No. FDA‐2009‐N‐0441 regarding Promotion of FDA‐Regulated Medical Products Using the Internet and Social Media Tools (find it here).

Novartis made many interesting proposals on how FDA should regulate the use of social media…

Sanofi-Aventis (S-A) submitted 14 pages of comments to Docket No. FDA‐2009‐N‐0441 regarding Promotion of FDA‐Regulated Medical Products Using the Internet and Social Media Tools (find it here).

“As part of routine monitoring of online discussions hosted, or with participation, by a…

Recently, Sanofi-Aventis has been having problems with its VOICES Facebook page (see “Disgruntled Patient Shuts Down sanofi-aventis Facebook Page”). I previously suggested S-A made a faux pas because it did NOT take its own advice about posting a Terms of…

I wanted to get the word out via a post, as I’m pretty excited that I can share with you some new information about where I’ll be speaking later this year. More than just speaking, I’ll be chairing the “Social…

FDA is considering issuing new guidelines regarding regulation of pharmaceutical use of the Internet for promoting drugs. The drug industry and online service providers like Google and Yahoo! hammered into the FDA’s head how important the Internet is for health…

“I actually think i did a very good job in closing down the FB page of Europes largest drugs company, something i am very proud of and something i havent finished with yet,” said Shirley Ledlie in a comment made…

Regular readers of Pharma Marketing Blog are familiar with Emily Jameson, aka “FDA Intern” and “PhRMA Intern.” Emily has moved on to accept a position with a leading pharma interactive media agency and is now Social Media Intern!

We’ve watched…

Shirley Ledlie, aka “Ann Adams”, “Julie Kahn”, “Jasper Boon”, and who-knows-how-many-more-phony-FB-aliases — the patient who claims sanofi-aventis (S-A) mislead her about the side effects of cancer drug Taxotere (see “sanofi aventis Feels the Social Media Pain. But Is It Authentic?”)…